Kyowa Hakko Kirin Nabs ProStrakan | February 28, 2011 Issue - Vol. 89 Issue 9 | Chemical & Engineering News
Volume 89 Issue 9 | p. 27 | Concentrates
Issue Date: February 28, 2011

Kyowa Hakko Kirin Nabs ProStrakan

Department: Business
Keywords: acquisition, specialty pharmaceuticals

Kyowa Hakko Kirin has agreed to pay roughly $470 million for Scottish specialty pharmaceutical firm ProStrakan Group. Tokyo-based KHK says the deal was driven by the potential to quickly expand in the U.S. and Europe. ProStrakan brings clinical and regulatory experience, along with a sales force that will enable KHK to launch its own pipeline of products in those markets. Several suitors have approached Pro­Strakan in recent months, but KHK was the best fit in terms of complementary product portfolios and geographic presence, Pro­Strakan’s chairman, Peter Allen, says.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment